Alberto Delgado-Iribarren (Alberto Delgado-Iribarren García-Campero)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 14

Top Topics

Newly Diagnosed

Respiratory Syndrome Coronavirus

Top Venues

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Kauzar Mohamed Mohamed, Kissy Guevara-Hoyer, Carlos Jiménez García, Laura García Bravo, Adolfo Jiménez-Huete, Antonia Rodríguez de la Peña, Beatriz Mediero Valeros, Cristina Cañizares Velázquez, Esther Culebras López, Noemí Cabello, Vicente Estrada, Ángel L Corbi, Miguel Fernández-Arquero, Alberto Ocaña, Alberto Delgado-Iribarren, Mercedes Martínez-Novillo, Estefanía Bolaños, Eduardo Anguita, Ascensión Peña, Celina Benavente, Javier David Benitez Fuentes, Pedro Pérez Segura, Silvia Sánchez-Ramón
Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors. Biomedicines 11 (4) (2023)
Kauzar Mohamed Mohamed, Kissy Guevara-Hoyer, Carlos Jiménez García, Laura García Bravo, Adolfo Jiménez-Huete, Antonia Rodríguez de la Peña, Beatriz Mediero Valeros, Cristina Cañizares Velázquez, Esther Culebras López, Noemí Cabello, Vicente Estrada, Ángel L Corbi, Miguel Fernández-Arquero, Alberto Ocaña, Alberto Delgado-Iribarren, Mercedes Martínez-Novillo, Estefanía Bolaños, Eduardo Anguita, Ascensión Peña, Celina Benavente, Javier David Benitez Fuentes, Pedro Pérez Segura, Silvia Sánchez-Ramón
Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors. Biomedicines 11 (4) (2023)
Javier E Cañada, Eva Ramírez de Arellano, Miguel Jiménez-Orellana, Esther Viedma, Aida Sánchez, Almudena Alhambra, Jennifer Villa, Alberto Delgado-Iribarren, Verónica Bautista, Noelia Lara, Silvia García-Cobos, Belén Aracil, Emilia Cercenado, María Pérez-Vázquez, Jesús Oteo-Iglesias
Carbapenemase-Producing Klebsiella pneumoniae in COVID-19 Intensive Care Patients: Identification of IncL-VIM-1 Plasmid in Previously Non-Predominant Sequence Types. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Javier E Cañada, Eva Ramírez de Arellano, Miguel Jiménez-Orellana, Esther Viedma, Aida Sánchez, Almudena Alhambra, Jennifer Villa, Alberto Delgado-Iribarren, Verónica Bautista, Noelia Lara, Silvia García-Cobos, Belén Aracil, Emilia Cercenado, María Pérez-Vázquez, Jesús Oteo-Iglesias
Carbapenemase-Producing Klebsiella pneumoniae in COVID-19 Intensive Care Patients: Identification of IncL-VIM-1 Plasmid in Previously Non-Predominant Sequence Types. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Esther Ríos, Sara Medrano, Mercedes Martínez, Consuelo Novella, Esther Marcos, Jose J Fernández, Alberto Delgado-Iribarren, Esther Culebras
Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose. Vaccines 10 (9) (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Ignacio Callejas-Caballero, Alba Ruedas-López, Arantxa Berzosa-Sánchez, Marta Illán-Ramos, Belén Joyanes-Abancens, Andrés Bodas-Pinedo, Sara Guillén-Martín, Beatriz Soto-Sánchez, Isabel García-Bermejo, David Molina Arana, Juan-Ignacio Alós, Elvira Baos-Muñoz, Alberto Delgado-Iribarren, Manuel E Fuentes-Ferrer, José T Ramos-Amador
A Prospective Study of the Serological, Clinical, and Epidemiological Features of a SARS-CoV-2 Positive Pediatric Cohort. Children (Basel, Switzerland) 9 (5) (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)